Patients with a higher comorbidity burden less often used quadruple therapy and had a worse prognosis, as well as its association with clinical outcomes, according to a prespecified subanalysis of the TITRATE-HF registry.
J. J. N. Krabbe, M. I. Wilde, A. Mosterd et al.· European Heart Journal· 0 citations
The need for improved implementation strategies to optimize guideline-directed therapy and dosing levels in the ageing HFrEF population is highlighted, with use of GDMT associated with better clinical outcomes, also among older patients.
J. J. N. Krabbe, M. I. Wilde, W. L. Verloop et al.· European Heart Journal· 0 citations
The findings underscore the need for implementation and dosing strategies that account for differences between men and women regarding GDMT implementation, side effects, change in left ventricular ejection fraction (LVEF), and clinical outcomes.
M. I. Wilde, J. J. N. Krabbe, L. J. Bouhuijzen et al.· European Heart Journal - Qua...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.